Health services

Tender description

NHS Arden & Greater East Midlands Commissioning Support Unit (NHS Arden & GEM CSU) on behalf of NHS England (North Midlands) would like to notify you of an opportunity to provide Diabetic Eye Screening Programme for Lot 1 Staffordshire and/or Lot 2 Shropshire Locality. Expressions of interest are sought from providers for two Diabetic Eye Screening contracts both with an anticipated start date of 1.1.2020 as the existing contracts will cease on 31.12.2019. There are approximately 2.9 million people with diabetes mellitus in England, Diabetic retinopathy is a complication of diabetes and is one of the leading causes of blindness. Diabetic retinopathy, if left untreated, can lead to sight loss which can have devastating effect on individuals and their families. By promptly identifying and treating the disease, these effects can reduce or be avoided completely. Diabetic eye screening is just one component of diabetes care; the screening programme should be integrated within routine diabetes care. The aims of the Diabetic Eye Screening Programme (DESP) is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment if necessary of sight threatening diabetic retinopathy, at the appropriate stage during the disease process. Commissioners across NHS England North Midlands are looking to procure DESP provision across Staffordshire locality. The Service being commissioned should be aligned to the National Diabetic Eye Screening Service Specification which aims to ensure a consistent and equitable approach across England, and to govern the provision and monitoring of the DESP. Staffordshire is a large geography area including; Stoke on Trent North Staffs, Staffordshire & Surrounds, Cannock Chase, East Staffordshire South East Staffordshire and Seisdon Peninsula. Access of screening will need to be considered carefully in order to deliver screening to all eligible patients who reside in Staffordshire. Current eligible cohort size is approximately 69 270 patients, with an expected annual growth between 5 %-6 %. The Service will need to undertake and perform the following objectives in order to meet the commissioning and Service Specification requirements: — Identify and validate the eligible population and ensure effective delivery with maximum coverage, — Deliver safe, effective, high quality, externally and independently monitored, and quality assured Diabetic Eye Screening Service — Lead to earlier detection, appropriate referral, effective treatment and improved outcomes; Deliver and support thorough suitable trained, competent, and qualified, clinical and non-clinical staff who, where relevant, participate in recognised ongoing continuing medical education (CME), continuous Professional Development (CPD), and Quality Assurance (QA) schemes; as well as have regular audits embedded within the service There are approximately 2.9 million people with diabetes mellitus in England, Diabetic retinopathy is a complication of diabetes and is one of the leading causes of blindness. Diabetic retinopathy, if left untreated, can lead to sight loss which can have devastating effect on individuals and their families. By promptly identifying and treating the disease, these effects can reduce or be avoided completely. Diabetic eye screening is just one component of diabetes care; the screening programme should be integrated within routine diabetes care. The aims of the DESP is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment if necessary of sight threatening diabetic retinopathy, at the appropriate stage during the disease process Commissioners across NHS England North Midlands are looking to procure DESP provision across Shropshire locality. The Service being commissioned should be align to the National Diabetic Eye Screening Service Specification which aims to ensure a consistent and equitable approach across England, and to govern the provision and monitoring of the DESP Shropshire covers a large geographical footprint expanding across Telford and Wrekin with some cross border issues with the Welsh border. Due to the geography span there is a requirement that access points are considered to enable patient accessibility and uptake of the screening provision. Current eligible cohort size is approximately 27 689 patients, with an expected annual growth between 5 %-7 %. The Service will need to undertake and perform the following objectives in order to meet the commissioning and Service Specification requirements: — Identify and validate the eligible population and ensure effective delivery with maximum coverage, — Deliver safe, effective, high quality, externally and independently monitored, and quality assured Diabetic Eye Screening Service, — Lead to earlier detection, appropriate referral, effective treatment and improved outcomes, — Deliver and support thorough suitable trained, competent, and qualified, clinical and non-clinical staff who, where relevant, participate in recognised ongoing continuing medical education (CME), continuous Professional Development (CPD), and Quality Assurance (QA) schemes; as well as have regular audits embedded within the service